These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11718261)

  • 1. Mouse astrocytoma models: embryonic stem cell mediated transgenesis.
    Ding H; Guha A
    J Neurooncol; 2001 Jul; 53(3):289-96. PubMed ID: 11718261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological and molecular progression of astrocytomas in a GFAP:12 V-Ha-Ras mouse astrocytoma model.
    Shannon P; Sabha N; Lau N; Kamnasaran D; Gutmann DH; Guha A
    Am J Pathol; 2005 Sep; 167(3):859-67. PubMed ID: 16127163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas.
    Ding H; Roncari L; Shannon P; Wu X; Lau N; Karaskova J; Gutmann DH; Squire JA; Nagy A; Guha A
    Cancer Res; 2001 May; 61(9):3826-36. PubMed ID: 11325859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
    Dai C; Celestino JC; Okada Y; Louis DN; Fuller GN; Holland EC
    Genes Dev; 2001 Aug; 15(15):1913-25. PubMed ID: 11485986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically engineered mouse models of astrocytoma: GEMs in the rough?
    Reilly KM; Jacks T
    Semin Cancer Biol; 2001 Jun; 11(3):177-91. PubMed ID: 11407943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse glioma gene expression profiling identifies novel human glioma-associated genes.
    Gutmann DH; Huang ZY; Hedrick NM; Ding H; Guha A; Watson MA
    Ann Neurol; 2002 Mar; 51(3):393-405. PubMed ID: 11891838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice.
    Weissenberger J; Steinbach JP; Malin G; Spada S; Rülicke T; Aguzzi A
    Oncogene; 1997 May; 14(17):2005-13. PubMed ID: 9160879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model.
    Ding H; Shannon P; Lau N; Wu X; Roncari L; Baldwin RL; Takebayashi H; Nagy A; Gutmann DH; Guha A
    Cancer Res; 2003 Mar; 63(5):1106-13. PubMed ID: 12615729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antisense glial fibrillary acidic protein complementary DNA on the growth, invasion, and adhesion of human astrocytoma cells.
    Rutka JT; Hubbard SL; Fukuyama K; Matsuzawa K; Dirks PB; Becker LE
    Cancer Res; 1994 Jun; 54(12):3267-72. PubMed ID: 8205549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astrocytes give rise to oligodendrogliomas and astrocytomas after gene transfer of polyoma virus middle T antigen in vivo.
    Holland EC; Li Y; Celestino J; Dai C; Schaefer L; Sawaya RA; Fuller GN
    Am J Pathol; 2000 Sep; 157(3):1031-7. PubMed ID: 10980141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of GFAP-δ and nestin in cerebral astrocytomas.
    Brehar FM; Arsene D; Brinduse LA; Gorgan MR
    Brain Tumor Pathol; 2015 Apr; 32(2):90-8. PubMed ID: 25178519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma.
    Zhu Y; Guignard F; Zhao D; Liu L; Burns DK; Mason RP; Messing A; Parada LF
    Cancer Cell; 2005 Aug; 8(2):119-30. PubMed ID: 16098465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation of astrocytes in transgenic mice expressing SV40 T antigen under the transcriptional control of the glial fibrillary acidic protein promoter.
    Danks RA; Orian JM; Gonzales MF; Tan SS; Alexander B; Mikoshiba K; Kaye AH
    Cancer Res; 1995 Oct; 55(19):4302-10. PubMed ID: 7671240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of glial fibrillary acidic protein, vimentin, fibronectin, and N-myc oncoprotein in primary human brain tumor cell explants.
    Mapstone TB; Galloway PG
    Pediatr Neurosurg; 1991-1992; 17(4):169-74. PubMed ID: 1668298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of oligodendrocytic mRNAs in glial tumors: changes associated with tumor grade and extent of neoplastic infiltration.
    Landry CF; Verity MA; Cherman L; Kashima T; Black K; Yates A; Campagnoni AT
    Cancer Res; 1997 Sep; 57(18):4098-104. PubMed ID: 9307299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early induction of angiogenetic signals in gliomas of GFAP-v-src transgenic mice.
    Theurillat JP; Hainfellner J; Maddalena A; Weissenberger J; Aguzzi A
    Am J Pathol; 1999 Feb; 154(2):581-90. PubMed ID: 10027415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging role of new transgenic mouse models in glioma research.
    Sonabend AM; Ulasov IV; Lesniak MS
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S7-13. PubMed ID: 18076321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capturing the molecular and biological diversity of high-grade astrocytoma in genetically engineered mouse models.
    Chow LM; Baker SJ
    Oncotarget; 2012 Jan; 3(1):67-77. PubMed ID: 22287481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8.
    Hong C; Maunakea A; Jun P; Bollen AW; Hodgson JG; Goldenberg DD; Weiss WA; Costello JF
    Cancer Res; 2005 May; 65(9):3617-23. PubMed ID: 15867356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural and cancer stem cells in tumor suppressor mouse models of malignant astrocytoma.
    Llaguno SA; Chen J; Kwon CH; Parada LF
    Cold Spring Harb Symp Quant Biol; 2008; 73():421-6. PubMed ID: 19022744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.